CRW vs. EMIS, INS, KOO, RENX, COG, INHC, FDBK, IQAI, TRLS, and DVRG
Should you be buying Craneware stock or one of its competitors? The main competitors of Craneware include EMIS Group (EMIS), Instem (INS), Kooth (KOO), Renalytix (RENX), Cambridge Cognition (COG), Induction Healthcare Group (INHC), Feedback (FDBK), IQ-AI (IQAI), Trellus Health (TRLS), and DeepVerge (DVRG). These companies are all part of the "health information services" industry.
Craneware (LON:CRW) and EMIS Group (LON:EMIS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, community ranking, media sentiment, institutional ownership and valuation.
In the previous week, Craneware and Craneware both had 1 articles in the media. Craneware's average media sentiment score of 0.63 beat EMIS Group's score of -0.05 indicating that Craneware is being referred to more favorably in the media.
EMIS Group has lower revenue, but higher earnings than Craneware. EMIS Group is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.
EMIS Group has a net margin of 17.23% compared to Craneware's net margin of 5.19%. EMIS Group's return on equity of 23.17% beat Craneware's return on equity.
Craneware has a beta of 0.14, suggesting that its share price is 86% less volatile than the S&P 500. Comparatively, EMIS Group has a beta of -0.13, suggesting that its share price is 113% less volatile than the S&P 500.
Craneware currently has a consensus price target of GBX 2,600, indicating a potential upside of 5.69%.
59.4% of Craneware shares are held by institutional investors. Comparatively, 105.6% of EMIS Group shares are held by institutional investors. 20.9% of Craneware shares are held by company insiders. Comparatively, 3.6% of EMIS Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Craneware pays an annual dividend of GBX 29 per share and has a dividend yield of 1.2%. EMIS Group pays an annual dividend of GBX 42 per share. Craneware pays out 13,809.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. EMIS Group pays out 8,936.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.
EMIS Group received 16 more outperform votes than Craneware when rated by MarketBeat users. Likewise, 75.38% of users gave EMIS Group an outperform vote while only 71.43% of users gave Craneware an outperform vote.
Summary
EMIS Group beats Craneware on 9 of the 16 factors compared between the two stocks.
Get Craneware News Delivered to You Automatically
Sign up to receive the latest news and ratings for CRW and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CRW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Craneware Competitors List
Related Companies and Tools
